移动应用程序在治疗2型糖尿病患者方面有多有效? 一个系统的文献审查协议
Carla Taramasco1,2, Carla Rimassa1,3, María Elena Lagos Garrido2,4
1Instituto de Tecnologías para la Innovación en Salud y Bienestar (ITiSB), Faculty of Engineering, Universidad Andrés Bello, Viña del Mar, Chile.
PloS one
|April 25, 2024
概括
本系统性审查研究了移动应用程序如何影响2型糖尿病成年人糖化血红蛋白水平. 有证据表明,移动健康干预可以支持糖尿病管理并改善患者的治疗结果.
科学领域:
- 数字健康数字健康
- 医疗信息学 医疗信息学
- 内分泌学 在内分泌学.
背景情况:
- 2型糖尿病 (T2DM) 是全球主要的死亡原因.
- 新的健康技术为慢性病管理提供了有前途的途径.
- 移动应用程序显示了支持T2DM患者自我管理的潜力.
研究的目的:
- 系统地审查移动应用程序使用对糖化血红蛋白 (HbA1c) 水平的影响.
- 评估T2DM成年患者的移动健康干预措施.
- 评估关于技术在T2DM管理中的作用的科学证据.
主要方法:
- 从2019年1月到2023年10月的随机对照试验 (RCT) 的系统审查.
- 在主要数据库 (MEDLINE,Embase,CINAHL等) 进行搜索. 使用受控和自然语言.
- 柯克兰偏差风险工具和GRADE质量和确定性评估方法.
主要成果:
- 分析重点是糖化血红蛋白水平的定量变化.
- 潜在的元分析来估计干预效应 (平均差异与95%的CI).
- 将使用随机效应模型和异质性评估 (科克兰的Q,I2).
结论:
- 移动健康应用程序对T2DM管理的有效性需要严格的评估.
- 应用程序质量的变化需要基于证据的评估.
- 本综述综合了当前关于移动应用对T2DM结果影响的证据.
相关概念视频
Diabetes: Management and Pharmacotherapy
268
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
268
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Carbohydrate Metabolism
11.1K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.1K
Diabetes: Symptoms, Diagnosis, and Complications
526
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
526
Oral Hypoglycemic Agents: Biguanides and Glitazones
192
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
192


